J&J, Medtronic Play The Slots Before Appeals Court In Stent Patent Debate
This article was originally published in The Gray Sheet
Executive Summary
Bare-metal stent intellectual property litigation between Johnson & Johnson/Cordis and Medtronic AVE presented before the Washington, D.C. federal appeals court May 6 hinges on the manufacturing method used to create holes in the devices
You may also be interested in...
J&J V. Medtronic: Palmaz-Schatz Infringement Claims Sway Appeals Panel
Medtronic's invocation of the doctrine of equivalents as a legal defense against Johnson & Johnson/Cordis failed to convince a three-judge appeals court panel that Medtronic had not infringed key Cordis patents
J&J V. Medtronic: Palmaz-Schatz Infringement Claims Sway Appeals Panel
Medtronic's invocation of the doctrine of equivalents as a legal defense against Johnson & Johnson/Cordis failed to convince a three-judge appeals court panel that Medtronic had not infringed key Cordis patents
Boston Scientific Liberty Stent Groomed To Face Next-Gen Cobalt Competitors
Boston Scientific will enroll approximately 400 patients in an ongoing clinical trial to support a PMA supplement for the firm's Taxus Liberty stent platform